| Authors: |
Zhu F; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Rajan S; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Hayes CF; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Kwong KY; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Goncalves AR; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Zemla AT; Global Security Computing Applications Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Lau EY; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Zhang Y; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Cai Y; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Goforth JW; Global Security Computing Applications Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Landajuela M; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Gilchuk P; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Kierny M; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Dippel A; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Amofah B; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Kaplan G; Biologics Engineering, R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Cadevilla Peano V; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Morehouse C; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Sparklin B; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Gopalakrishnan V; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Tuffy KM; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Nguyen A; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Beloor J; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Kijak G; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Liu C; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Dijokaite-Guraliuc A; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Mongkolsapaya J; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand., Screaton GR; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Petersen BK; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Desautels TA; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Bennett D; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Conti S; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Segelke BW; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Arrildt KT; Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Kaul S; Global Security Computing Applications Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Grzesiak EA; Global Security Computing Applications Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., da Silva FL; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Bates TW; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Earnhart CG; Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, US Department of Defense, Frederick, MD 21703, USA., Hopkins S; Joint Research and Development Inc., Stafford, VA 22556, USA., Sundaram S; Center for Bioengineering, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA., Esser MT; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Francica JR; Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Faissol DM; Computational Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA. |
